Cargando…
Implementation of Next-Generation Sequencing in Saudi Arabia for HER2-Positive Breast Cancer
Breast cancer is a common malignancy that poses a hazard to women's health. In 2021, around 2.3 million new cases are predicted to be discovered, with a mortality rate of 6.9% on average. Breast cancer accounts for 14.8% of malignancies among the Saudis with an 8.5% fatality rate. Breast cancer...
Autores principales: | Nassir, Rami, Esheba, Ghada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913378/ https://www.ncbi.nlm.nih.gov/pubmed/35280536 http://dx.doi.org/10.1016/j.sjbs.2021.10.044 |
Ejemplares similares
-
HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
por: Morsberger, Laura, et al.
Publicado: (2022) -
Over-the-Counter Medication Use among Parents in Saudi Arabia
por: Mirdad, Ola A., et al.
Publicado: (2023) -
Evaluation of Next Generation Sequencing for Detecting HER2 Copy Number in Breast and Gastric Cancers
por: Niu, Dongfeng, et al.
Publicado: (2020) -
The use of the nutritional supplements during the covid-19 outbreak in Saudi Arabia: A cross-sectional study
por: Hafiz, Nada Mohammed, et al.
Publicado: (2023) -
Next Generation Sequencing Based Non-invasive Prenatal Testing (NIPT): First Report From Saudi Arabia
por: Alyafee, Yusra, et al.
Publicado: (2021)